TrademarkOpen
Search / United States / 98427629

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark / Service Mark

KEYSOURCE +

Allowed — statement of use stage
Third Extension - Granted
Used for: Pharmaceuticals for pain management; pharmaceuticals for the treatment of allergies; pharmaceuticals for the treatment…
Show more

Class 5: Pharmaceuticals for pain management; pharmaceuticals for the treatment of allergies; pharmaceuticals for the treatment and prevention of digestive, cardiovascular, immune system, urology, central nervous system, respiratory, bone, eye, ear, nose, throat, dermatological, ophthalmological, endocrine, musculo-skeletal, obstetric and gynecological, urinary and gastrointestinal diseases, infections, and conditions; nutritional and dietary supplements
Class 35: Distributorship services in the field of pharmaceutical products

Class 5 – Pharmaceuticals & supplementsClass 35 – Advertising & retail

Status timeline

  1. 29 Feb 2024
    Application filed
    New Application Entered
  2. 17 Sep 2024
    Assigned to an examining attorney
    Assigned To Examiner
  3. 1 Oct 2024
    Approved for publication
    Approved For Pub - Principal Register
  4. 12 Nov 2024
    Published for opposition
    Published For Opposition
  5. 24 Dec 2024
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  6. 2 May 2025
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  7. 8 Dec 2025
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  8. 8 Apr 2026
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
All 20 events
2026-04-09Notice Of Approval Of Extension Request E-Mailed
2026-04-08Sou Teas Extension Received
2026-04-08Sou Extension 3 Filed
2026-04-08Sou Extension 3 Granted
2025-12-08Sou Teas Extension Received
2025-12-08Sou Extension 2 Filed
2025-12-08Sou Extension 2 Granted
2025-12-08Notice Of Approval Of Extension Request E-Mailed
2025-05-02Sou Teas Extension Received
2025-05-02Sou Extension 1 Filed
2025-05-02Sou Extension 1 Granted
2025-05-02Notice Of Approval Of Extension Request E-Mailed
2024-12-24Noa Mailed - Sou Required From Applicant
2024-11-12Published For Opposition
2024-11-12Official Gazette Publication Confirmation E-Mailed
2024-10-23Notification Of Notice Of Publication E-Mailed
2024-10-01Approved For Pub - Principal Register
2024-09-17Assigned To Examiner
2024-07-11New Application Office Supplied Data Entered
2024-02-29New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceuticals for pain management; pharmaceuticals for the treatment of allergies; pharmaceuticals for the treatment and prevention of digestive, cardiovascular, immune system, urology, central nervous system, respiratory, bone, eye, ear, nose, throat, dermatological, ophthalmological, endocrine, musculo-skeletal, obstetric and gynecological, urinary and gastrointestinal diseases, infections, and conditions; nutritional and dietary supplements

Class 35 Advertising & retail

Distributorship services in the field of pharmaceutical products

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 10 Apr 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.